{"id":"doi:10.1001/jama.2016.11004","kind":"article","title":"Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease","authors":["Dhruv S. Kazi","Andrew Edward Moran","Pamela G. Coxson","Joanne M. Penko","Daniel A. Ollendorf","Steven D. Pearson","Jeffrey A. Tice","David Guzman","Kirsten B. Bibbins-Domingo"],"author_count":9,"year":2016,"published":"2016-08-16","venue":"JAMA","cited_by":382,"doi":"10.1001/jama.2016.11004","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1001/jama.2016.11004","archive_url":"https://space-kitty.com/papers/doi:10.1001/jama.2016.11004","updated":null,"pmid":"27533159","pmcid":null,"openalex_id":"W2511907480","pdf_url":"https://jamanetwork.com/journals/jama/articlepdf/2544639/joi160091.pdf","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}